1379 results
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
FDA recommends, ... ADA/KDIGO Consensus ... evidence-based pharmacologic ... Diabetes #CKD #ADA ... #KDIGO #eGFR #Insulin
KDIGO Definition of Acute Kidney Injury (AKI)

#Diagnosis #Nephrology #KDIGO #AKI #Acute #Kidney #Injury
KDIGO Definition ... Diagnosis #Nephrology #KDIGO
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
normal range (KDIGO ... hypercalcemia (KDIGO ... #Dose #Dosing #Pharmacology
Cephalosporin Coverage by Generation - HENPECKS Mnemonic
1st Gen: PEK (Proteus, E. coli, Klebsiella)
2nd Gen: HNPEK (Add
2nd Gen: HNPEK (Add ... Gen: HENPECKS (Add ... HENPECKS + PsA + A (Add ... HENPECKS + PSA + A (Add ... #antibiotics #pharmacology
Abdominal Aortic Aneurysm (AAA) Management and Surveillance

- Screening should be considered for more than just men
Aortic Aneurysm (AAA ... Ana Casanegra ... Aortic #Aneurysm #AAA
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
The ADA recommends ... Neuropathy #Diabetes #Pharmacology
Elagolix (Orilissa) - Pharmacology Review
Elagolix is a small-molecule GnRH antagonist recently approved by the FDA for
Elagolix (Orilissa) - Pharmacology ... approved by the FDA ... #Pharmacology #Elagolix
With the recent publication of the FDA Guidance on alcohol-based hand sanitizer compounding, I thought to
publication of the FDA ... with both the FDA ... FDA is also encouraging ... #Compounding #Pharmacology
Tuberculous Pleural Effusions - Tests and Biomarkers
Age + fever + red blood cells + ADA -
blood cells + ADA ... high specificity ADA ... lymphocytes % + ADA ... and specificity ADA ... and specificity ADA
Mechanism of Action of Platelet Aggregation Inhibitors
- COX Inhibitors
- ADP Inhibitors
- GP IIb/IIIa Receptor Blockers

#Antiplatelet #Pharmacolgy
Inhibitors - ADP ... #Antiplatelet #Pharmacolgy